GSK3745417
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK3745417, covering 2025-03-25 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors [Phase 1]